IFNA1 and neoplasm: The molecules can activate stimulator of interferon genes (STING) to produce IFN Is (IFNα and IFNβ), beneficially modulating the tumor immune environment by regulating monocyte to macrophage polarization and influencing natural killer and dendritic cell activity which contributes to anti-tumor immunity [9].